ISIN | CH0330968717 |
---|---|
Valor Number | 33096871 |
Bloomberg Global ID | |
Fund Name | Swisscanto (CH) Index Equity Fund World ex CH GT CHF |
Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
Fund Provider | Swisscanto Fondsleitung AG |
Representative in Switzerland | |
Distributor(s) | Schweizerische Kantonalbanken |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel) |
Investment Strategy *** | The investment objective of the fund is to replicate the risk and return characteristics of the reference index.The fund primarily invests directly and indirectly in shares and other equity securities that are contained in the reference index.The use of derivatives equates to neither leveraging nor short selling with regard to the fund assets. |
Peculiarities |
Current Price * | 216.75 CHF | 13.11.2024 |
---|---|---|
Previous Price * | 216.79 CHF | 12.11.2024 |
52 Week High * | 217.41 CHF | 11.11.2024 |
52 Week Low * | 168.41 CHF | 30.11.2023 |
NAV * | 216.75 CHF | 13.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 958,117,169 | |
Unit/Share Assets *** | 92,011,686 | |
Trading Information SIX |
YTD Performance | +26.76% |
29.12.2023 - 13.11.2024
29.12.2023 13.11.2024 |
---|---|---|
1 month | +2.95% |
14.10.2024 - 13.11.2024
14.10.2024 13.11.2024 |
3 months | +10.41% |
13.08.2024 - 13.11.2024
13.08.2024 13.11.2024 |
6 months | +8.15% |
13.05.2024 - 13.11.2024
13.05.2024 13.11.2024 |
1 year | +29.14% |
13.11.2023 - 13.11.2024
13.11.2023 13.11.2024 |
2 years | +37.31% |
14.11.2022 - 13.11.2024
14.11.2022 13.11.2024 |
3 years | +17.41% |
15.11.2021 - 13.11.2024
15.11.2021 13.11.2024 |
5 years | +60.34% |
13.11.2019 - 13.11.2024
13.11.2019 13.11.2024 |
Equity Participation Rate in % | 94.95 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Xtrackers MSCI USA ETF 1C | 24.20% | |
---|---|---|
iShares MSCI USA ETF USD Acc | 24.06% | |
iShares Core S&P 500 ETF USD Acc | 9.41% | |
Vanguard S&P 500 ETF USD Acc | 9.41% | |
E-mini S&P 500 Future Sept 24 | 1.21% | |
Novo Nordisk A/S Class B | 0.66% | |
ASML Holding NV | 0.53% | |
AstraZeneca PLC | 0.41% | |
Shell PLC | 0.33% | |
SAP SE | 0.33% | |
Last data update | 31.08.2024 |
TER | 0.24% |
---|---|
TER date | 29.02.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.35% |
Ongoing Charges *** | 0.22% |
SRRI ***
|
|
SRRI date *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |